Learn Treat Resources Connect About Donate
Language
Color
Text size + -
A
×
Language
×
Color
Text size
A A A A
  • Resources
  • Welcome
  • Patient Brochure
  • Patient Brochure (United Kingdom)
  • Multimedia
  • Wet AMD Infographic
  • 2013 International Wet AMD Report - Berlin
  • Asia-Pacific Whitepaper
  • Australian White Paper
  • Latin American Wet AMD White Paper
  • 2011 International Wet AMD Report - Berlin
  • Check Your Eyesight
  • Media Resources
  • Links
  • News
  • Glossary
News
Play Pause

  • Positive phase 2 trial results of anti-VEGF abicipar pegol for treating wet AMD
  • Vitreous separation in wet AMD patients linked to fewer anti-VEGF injections
  • As-needed anti-VEGF regimen shown to be effective for the treatment of wet AMD
  • Greatest vision gains occur during early stages of anti-VEGF treatment for wet AMD
  • Potential Topical Treatment in the Future for Macular Degeneration
  • MicroRNAs Block Abnormal Blood Vessel Growth While Still Maintaining the Health of Normal Vessels
  • New Treatment Approach in Mice Regresses Abnormal Vessels in Wet Macular Degeneration
  • Discussions on the Retina and AMD from the American Academy of Opthalmology 2013: Hear from the Experts
  • New Initiative by the American Academy of Ophthalmology Harnesses Technology to Improve Patient Outcomes
  • BROUGHT TO YOU BY
  • The Angiogenesis Foundation
  • One Broadway, 14th fl, Cambridge, MA 02142
  • (617) 401-2779
  • info@scienceofcrc.org
  • Home
  • About
  • Learn
  • Treat
  • Resources
  • Glossary
  • Donate
  • Privacy Policy
  • Disclaimer
  • Site Supporters
This site has been determined by HON in Geneva, Switzerland to comply with standards for trustworthy health information.